DOCSLIB.ORG

Case Definitions for Select Reportable Diseases in Florida Florida Department of Health Bureau of Epidemiology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Case Definitions for Select Reportable Diseases in Florida Florida Department of Health Bureau of Epidemiology DRAFT Version1.2 Surveillance Case Definitions for Select Reportable Diseases in Florida Florida Department of Health Bureau of Epidemiology Department of Health Bureau of Epidemiology 4052 Bald Cypress Way, Bin A-12 Tallahassee, FL 32399-1720 Fax 850-922-9299 Confidential Fax 850-414-6894 850-245-4401 (24 hours/7 days) August 2008 DRAFT Version1.2 Contents INTRODUCTION ....................................................................................................... 1 List of Sterile and Non-Sterile Sites....................................................................... 2 Suspect Immediately: Report immediately, 24 hours a day, 7 days a week (24/7), by phone upon initial clinical suspicion or laboratory test order ......... 2 Immediately: Report immediately 24 hours a day, 7 days a week (24/7) by phone upon diagnosis .................................................................................... 2 Isolates or specimens are required to be submitted to the Bureau of Laboratories as required by Chapter 64D-3 Florida Administrative Code....... 2 HOW TO USE INFORMATION IN THIS REPORT.................................................... 2 Acute Arboviral Diseases (neuroinvasive and non-neuroinvasive).................... 3 reporting code = 06210 Western Equine Encephalitis virus (neuroinvasive) = 06211 Western Equine Encephalitis virus (non-neuroinvasive) = 06220 Eastern Equine Encephalitis virus (neuroinvasive) = 06221 Eastern Equine Encephalitis virus (non-neuroinvasive) = 06230 St. Louis Encephalitis virus (neuroinvasive) = 06231 St. Louis Encephalitis virus (non-neuroinvasive) = 06250 California serogroup virus (neuroinvasive) = 06251 California serogroup virus (non-neuroinvasive) = 06620 Venezuelan Equine Encephalitis virus (neuroinvasive) = 06621 Venezuelan Equine Encephalitis virus (non-neuroinvasive) = 06630 West Nile virus (neuroinvasive) = 06631 West Nile virus (non-neuroinvasive) Amebic Encephalitis (Naegleria fowleri, Balamuthia mandrillaris, Acanthamoeba excluding A. keratitis)................................................................... 6 Anaplasmosis/Ehrlichiosis, Human (see Ehrlichiosis) ........................................ 9 Anthrax..................................................................................................................... 9 Arsenic Poisoning ................................................................................................. 10 Botulism................................................................................................................. 11 Brucellosis............................................................................................................. 12 Campylobacteriosis .............................................................................................. 13 Carbon Monoxide Poisoning................................................................................ 14 Cholera, Vibrio....................................................................................................... 16 Ciguatera Poisoning.............................................................................................. 17 Creutzfeldt-Jakob Disease (CJD) ......................................................................... 18 Cryptosporidiosis.................................................................................................. 19 Cyclosporiasis....................................................................................................... 20 i DRAFT Version1.2 Dengue Fever......................................................................................................... 21 Diphtheria .............................................................................................................. 22 Ehrlichiosis/Anaplasmosis, Human..................................................................... 23 Encephalitis, Other (Non-arboviral) ..................................................................... 25 Escherichia coli, Shiga Toxin Producing (STEC) ............................................... 26 Giardiasis ............................................................................................................... 27 Glanders (Burkholderia mallei) ........................................................................... 28 Haemophilus influenzae (Invasive Disease) ....................................................... 29 Hansen’s Disease (Leprosy)................................................................................. 30 Hantavirus Infection (Hantavirus Pulmonary Syndrome) .................................. 31 Hemolytic Uremic Syndrome (HUS)..................................................................... 32 Hepatitis A ............................................................................................................. 33 Hepatitis B, Acute.................................................................................................. 34 Hepatitis B, Chronic .............................................................................................. 35 Hepatitis B Surface Antigen (HBsAg+), in Pregnant Women ............................ 36 Hepatitis B, Perinatal............................................................................................. 36 Hepatitis C, Acute.................................................................................................. 37 Hepatitis C, (Past or Present Infection) ............................................................... 38 Hepatitis C, (Past or Present Infection) ............................................................... 38 Hepatitis D.............................................................................................................. 39 Hepatitis E.............................................................................................................. 40 Hepatitis G.............................................................................................................. 41 Influenza A, Novel or Pandemic Strains.............................................................. 42 Influenza-Associated Pediatric Mortality ............................................................ 44 Lead Poisoning...................................................................................................... 45 Legionellosis.......................................................................................................... 46 Leptospirosis......................................................................................................... 47 Listeriosis .............................................................................................................. 48 Lyme Disease......................................................................................................... 49 Malaria .................................................................................................................... 53 ii DRAFT Version1.2 Measles (Rubeola)................................................................................................. 54 Melioidosis (Burkholderia pseudomallei) ........................................................... 56 Meningitis, Bacterial, Cryptococcal, Mycotic...................................................... 57 Meningococcal Disease........................................................................................ 58 Mercury Poisoning ................................................................................................ 59 Mumps.................................................................................................................... 60 Neurotoxic Shellfish Poisoning ........................................................................... 62 Pertussis ............................................................................................................... 63 Pesticide-Related Illness and Injury .................................................................... 64 Plague .................................................................................................................... 66 Poliomyelitis, Paralytic ......................................................................................... 67 Poliomyelitis, Nonparalytic .................................................................................. 67 Psittacosis.............................................................................................................. 69 Q Fever, Acute (Coxiella burnetii) ........................................................................ 70 Q Fever, Chronic (Coxiella burnetii) .................................................................... 71 Rabies, Animal ...................................................................................................... 72 Rabies, Human ...................................................................................................... 73 Rabies, Possible Exposure .................................................................................. 74 Ricin Toxicity......................................................................................................... 75 Rocky Mountain Spotted Fever............................................................................ 76 Rubella ................................................................................................................... 78 Rubella, Congenital Syndrome ............................................................................ 80 Salmonellosis .......................................................................................................
Load more

Recommended publications
  • European Conference on Rare Diseases
    EUROPEAN CONFERENCE ON RARE DISEASES Luxembourg 21-22 June 2005 EUROPEAN CONFERENCE ON RARE DISEASES Copyright 2005 © Eurordis For more information: www.eurordis.org Webcast of the conference and abstracts: www.rare-luxembourg2005.org TABLE OF CONTENT_3 ------------------------------------------------- ACKNOWLEDGEMENTS AND CREDITS A specialised clinic for Rare Diseases : the RD TABLE OF CONTENTS Outpatient’s Clinic (RDOC) in Italy …………… 48 ------------------------------------------------- ------------------------------------------------- 4 / RARE, BUT EXISTING The organisers particularly wish to thank ACKNOWLEDGEMENTS AND CREDITS 4.1 No code, no name, no existence …………… 49 ------------------------------------------------- the following persons/organisations/companies 4.2 Why do we need to code rare diseases? … 50 PROGRAMME COMMITTEE for their role : ------------------------------------------------- Members of the Programme Committee ……… 6 5 / RESEARCH AND CARE Conference Programme …………………………… 7 …… HER ROYAL HIGHNESS THE GRAND DUCHESS OF LUXEMBOURG Key features of the conference …………………… 12 5.1 Research for Rare Diseases in the EU 54 • Participants ……………………………………… 12 5.2 Fighting the fragmentation of research …… 55 A multi-disciplinary approach ………………… 55 THE EUROPEAN COMMISSION Funding of the conference ……………………… 14 Transfer of academic research towards • ------------------------------------------------- industrial development ………………………… 60 THE GOVERNEMENT OF LUXEMBOURG Speakers ……………………………………………… 16 Strengthening cooperation between academia
    [Show full text]
  • PREPARING for ICD-10 Is Your Practice Ready?
    PREPARING FOR ICD-10 Is Your Practice Ready? Reproductive Health Update – Regional Meeting APRIL 24 , 2015 presenter DENISE WALSH, CPC Senior Consultant SHR ASSOCIATES, INC. PREPARING FOR ICD-10 Is Your Practice Ready? Since 1981, SHR Associates, Inc. (SHR) has been dedicated to providing physicians, hospitals and health care organizations with the business tools and resources necessary to respond and successfully operate in today’s ever-changing health care environment. 2 www.shrassociatesinc.com / 410‐897‐9888 / [email protected] Presentation Objectives: Define ICD-10 and the differences between ICD-9 and ICD-10. Outline the impact of ICD-10 on your practice. Explain how to create an action plan for your practice’s transition to ICD-10. Medical Documentation – Explain the importance of complete and accurate documentation to support and accurately code ICD-10. Review the type of patient information that must be documented to support ICD-10. ICD-10 codes – Instruct how to accurately code for your frequently encountered medical conditions. 3 www.shrassociatesinc.com / 410‐897‐9888 / [email protected] ICD‐10 IMPLEMENTATION: OCTOBER 1, 2015 4 www.shrassociatesinc.com / 410‐897‐9888 / [email protected] Reproductive Health Update – Regional Meeting Baltimore, MD –April 24, 2015 Presented by SHR Associates, Inc. 1 PREPARING FOR ICD-10 Is Your Practice Ready? What is ICD‐10 and How Will it Help? The purpose of ICD‐10 is to improve clinical communication and accuracy. ___ It will help providers capture more data about signs, symptoms, risk factors and co‐morbidities to better describe the overall clinical issue. ___ It will require more precise documentation of clinical care and allow for more accuracy when determining medical necessity.
    [Show full text]
  • Managing Communicable Diseases in Child Care Settings
    MANAGING COMMUNICABLE DISEASES IN CHILD CARE SETTINGS Prepared jointly by: Child Care Licensing Division Michigan Department of Licensing and Regulatory Affairs and Divisions of Communicable Disease & Immunization Michigan Department of Health and Human Services Ways to Keep Children and Adults Healthy It is very common for children and adults to become ill in a child care setting. There are a number of steps child care providers and staff can take to prevent or reduce the incidents of illness among children and adults in the child care setting. You can also refer to the publication Let’s Keep It Healthy – Policies and Procedures for a Safe and Healthy Environment. Hand Washing Hand washing is one of the most effective way to prevent the spread of illness. Hands should be washed frequently including after diapering, toileting, caring for an ill child, and coming into contact with bodily fluids (such as nose wiping), before feeding, eating and handling food, and at any time hands are soiled. Note: The use of disposable gloves during diapering does not eliminate the need for hand washing. The use of gloves is not required during diapering. However, if gloves are used, caregivers must still wash their hands after each diaper change. Instructions for effective hand washing are: 1. Wet hands under warm, running water. 2. Apply liquid soap. Antibacterial soap is not recommended. 3. Vigorously rub hands together for at least 20 seconds to lather all surfaces of the hands. Pay special attention to cleaning under fingernails and thumbs. 4. Thoroughly rinse hands under warm, running water. 5.
    [Show full text]
  • Regulations for Disease Reporting and Control
    Department of Health Regulations for Disease Reporting and Control Commonwealth of Virginia State Board of Health October 2016 Virginia Department of Health Office of Epidemiology 109 Governor Street P.O. Box 2448 Richmond, VA 23218 Department of Health Department of Health TABLE OF CONTENTS Part I. DEFINITIONS ......................................................................................................................... 1 12 VAC 5-90-10. Definitions ............................................................................................. 1 Part II. GENERAL INFORMATION ............................................................................................... 8 12 VAC 5-90-20. Authority ............................................................................................... 8 12 VAC 5-90-30. Purpose .................................................................................................. 8 12 VAC 5-90-40. Administration ....................................................................................... 8 12 VAC 5-90-70. Powers and Procedures of Chapter Not Exclusive ................................ 9 Part III. REPORTING OF DISEASE ............................................................................................. 10 12 VAC 5-90-80. Reportable Disease List ....................................................................... 10 A. Reportable disease list ......................................................................................... 10 B. Conditions reportable by directors of
    [Show full text]
  • LIST of OCCUPATIONAL DISEASES (Revised 2010)
    LIST OF OCCUPATIONAL DISEASES (revised 2010) Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases Occupational Safety and Health Series, No. 74 List of occupational diseases (revised 2010) Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases INTERNATIONAL LABOUR OFFICE • GENEVA Copyright © International Labour Organization 2010 First published 2010 Publications of the International Labour Office enjoy copyright under Protocol 2 of the Universal Copyright Convention. Nevertheless, short excerpts from them may be reproduced without authorization, on condition that the source is indicated. For rights of reproduction or translation, application should be made to ILO Publications (Rights and Permissions), International Labour Office, CH-1211 Geneva 22, Switzerland, or by email: pubdroit@ ilo.org. The International Labour Office welcomes such applications. Libraries, institutions and other users registered with reproduction rights organizations may make copies in accordance with the licences issued to them for this purpose. Visit www.ifrro.org to find the reproduction rights organization in your country. ILO List of occupational diseases (revised 2010). Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases Geneva, International Labour Office, 2010 (Occupational Safety and Health Series, No. 74) occupational disease / definition. 13.04.3 ISBN 978-92-2-123795-2 ISSN 0078-3129 Also available in French: Liste des maladies professionnelles (révisée en 2010): Identification et reconnaissance des maladies professionnelles: critères pour incorporer des maladies dans la liste des maladies professionnelles de l’OIT (ISBN 978-92-2-223795-1, ISSN 0250-412x), Geneva, 2010, and in Spanish: Lista de enfermedades profesionales (revisada en 2010).
    [Show full text]
  • ICD-10 International Statistical Classification of Diseases and Related Health Problems
    ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision Volume 2 Instruction manual 2010 Edition WHO Library Cataloguing-in-Publication Data International statistical classification of diseases and related health problems. - 10th revision, edition 2010. 3 v. Contents: v. 1. Tabular list – v. 2. Instruction manual – v. 3. Alphabetical index. 1.Diseases - classification. 2.Classification. 3.Manuals. I.World Health Organization. II.ICD-10. ISBN 978 92 4 154834 2 (NLM classification: WB 15) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]
  • FAQ REGARDING DISEASE REPORTING in MONTANA | Rev
    Disease Reporting in Montana: Frequently Asked Questions Title 50 Section 1-202 of the Montana Code Annotated (MCA) outlines the general powers and duties of the Montana Department of Public Health & Human Services (DPHHS). The three primary duties that serve as the foundation for disease reporting in Montana state that DPHHS shall: • Study conditions affecting the citizens of the state by making use of birth, death, and sickness records; • Make investigations, disseminate information, and make recommendations for control of diseases and improvement of public health to persons, groups, or the public; and • Adopt and enforce rules regarding the reporting and control of communicable diseases. In order to meet these obligations, DPHHS works closely with local health jurisdictions to collect and analyze disease reports. Although anyone may report a case of communicable disease, such reports are submitted primarily by health care providers and laboratories. The Administrative Rules of Montana (ARM), Title 37, Chapter 114, Communicable Disease Control, outline the rules for communicable disease control, including disease reporting. Communicable disease surveillance is defined as the ongoing collection, analysis, interpretation, and dissemination of disease data. Accurate and timely disease reporting is the foundation of an effective surveillance program, which is key to applying effective public health interventions to mitigate the impact of disease. What diseases are reportable? A list of reportable diseases is maintained in ARM 37.114.203. The list continues to evolve and is consistent with the Council of State and Territorial Epidemiologists (CSTE) list of Nationally Notifiable Diseases maintained by the Centers for Disease Control and Prevention (CDC). In addition to the named conditions on the list, any occurrence of a case/cases of communicable disease in the 20th edition of the Control of Communicable Diseases Manual with a frequency in excess of normal expectancy or any unusual incident of unexplained illness or death in a human or animal should be reported.
    [Show full text]
  • History of the Statistical Classification of Diseases and Causes of Death
    Copyright information All material appearing in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated. Suggested citation Moriyama IM, Loy RM, Robb-Smith AHT. History of the statistical classification of diseases and causes of death. Rosenberg HM, Hoyert DL, eds. Hyattsville, MD: National Center for Health Statistics. 2011. Library of Congress Cataloging-in-Publication Data Moriyama, Iwao M. (Iwao Milton), 1909-2006, author. History of the statistical classification of diseases and causes of death / by Iwao M. Moriyama, Ph.D., Ruth M. Loy, MBE, A.H.T. Robb-Smith, M.D. ; edited and updated by Harry M. Rosenberg, Ph.D., Donna L. Hoyert, Ph.D. p. ; cm. -- (DHHS publication ; no. (PHS) 2011-1125) “March 2011.” Includes bibliographical references. ISBN-13: 978-0-8406-0644-0 ISBN-10: 0-8406-0644-3 1. International statistical classification of diseases and related health problems. 10th revision. 2. International statistical classification of diseases and related health problems. 11th revision. 3. Nosology--History. 4. Death- -Causes--Classification--History. I. Loy, Ruth M., author. II. Robb-Smith, A. H. T. (Alastair Hamish Tearloch), author. III. Rosenberg, Harry M. (Harry Michael), editor. IV. Hoyert, Donna L., editor. V. National Center for Health Statistics (U.S.) VI. Title. VII. Series: DHHS publication ; no. (PHS) 2011- 1125. [DNLM: 1. International classification of diseases. 2. Disease-- classification. 3. International Classification of Diseases--history. 4. Cause of Death. 5. History, 20th Century. WB 15] RB115.M72 2011 616.07’8012--dc22 2010044437 For sale by the U.S.
    [Show full text]
  • Neglected Diseases
    Neglected Diseases What is a neglected disease? Why do we call these diseases neglected? How many people are affected by neglected diseases? What are some examples of neglected diseases? What can be done to prevent neglected diseases? How can neglected diseases be treated? Where can people get more information about neglected diseases? What is a neglected disease? Neglected diseases are conditions that inflict severe health burdens on the world’s poorest people. Many of these conditions are infectious diseases that are most prevalent in tropical climates, particularly in areas with unsafe drinking water, poor sanitation, substandard housing and little or no access to health care. Why do we call these diseases neglected? Diseases are said to be neglected if they are often overlooked by drug developers or by others instrumental in drug access, such as government officials, public health programs and the news media. Typically, private pharmaceutical companies cannot recover the cost of developing and producing treatments for these diseases. Another reason neglected diseases are not considered high priorities for prevention or treatment is because they usually do not affect people who live in the United States and other developed nations. Neglected diseases also lack visibility because they usually do not cause dramatic outbreaks that kill large numbers of people. Rather, such diseases usually exact their toll over a longer period of time, leading to crippling deformities, severe disabilities and/or relatively slow deaths. How many people are affected by neglected diseases? The World Health Organization (WHO) estimates that more than 1 billion people -- one- sixth of the world’s population -- suffer from one or more neglected diseases.
    [Show full text]
  • Infection Control Management of Infectious Diseases Summary Table
    Infection Control Management of Infectious Diseases Summary Table Version 2.8 (November 2020) Table of Content Scope ....................................................................................................................................................... 1 Contact Precautions ............................................................................................................................. 2 Droplet Precautions .............................................................................................................................. 2 Airborne Precautions ............................................................................................................................ 2 Cleaning................................................................................................................................................ 3 References .............................................................................................................................................. 4 Table: List of Diseases .......................................................................................................................... 6 Appendix: Priority guide for allocation of isolation rooms &/or cohorting ................................... 32 Version control and changes history Version Date from Date to Amendment 2.8 27/11/2020 Current Minor updates & URL references 2.7 2/12/2019 27/11/2020 Minor updates 2.6 5/04/2019 2/12/2019 Minor updates 2.5 10/02/2017 5/04/2019 Minor updates 2.4 22/06/2016 03/01/2017 Minor
    [Show full text]
  • A Classified List of Diseases and an Alphabetical List of the Causes of Death
    Circular No. 34, A CLASSIFIED LIST OF DISEASES AND AN Alphabetical List of the Causes of Death. A CLASSIFIED LIST OF DISEASES AND AN Alphabetical List of the Causes of Death, Arranged to Refer One to the Other by Numbers, FOR THE USE OF REGISTRARS OF VITAL STATISTICS IN CONNECTICUT. With. Explanatory Remarks BY THE SUPERINTENDENT OF REGISTRATION. NEW HAVEN: TUTTLE, MOREHOUSE & TAYLOR, PRINTERS. 1887. To the Registrars of Births, Marriages and Deaths in the Towns of Connecticut: These few pages have been prepared for the use of the Regis- trars of Vital Statistics in the towns of Connecticut. The pur- pose is to afford them some ready help, in making the annual abstract of the deaths in their respective towns, which the law requires them to make and to send to the Secretary of the State Board of Health. By a recent legislation enacted in 1886, the town clerk of every town in the state, except New Haven, is made ex-officio the Registrar of Births, Marriages and Deaths for the town of which he is the Clerk. It is no reflection upon the intelligence of town clerks to say that they have not, and cannot have, as a consequence of being charged with new and unfamiliar duties, at once, the knowledge requisite to do well and correctly a portion of the work which the law imposes upon Registrars of Vital Statistics. Town <?lerks have not (with very few exceptions), theadvantages of a medical education. The varied and mixed systems of nam- ing diseases, in use among Doctors, are to almost all of them unknown.
    [Show full text]
  • The Spectrum of Autoimmune Diseases
    Sarah Ballantyne, PhD 1717 The Spectrum of Autoimmune Diseases The following is a list of diseases that are either confirmed autoimmune diseases or for which there is very strong scientific evidence for autoimmune origins: Acute brachial neuropathy (also Atrophic polychondritis (also known Besnier-Boeck disease (also known A known as acute brachial radiculitis, as systemic chondromalacia and as sarcoidosis) neuralgic amyotrophy, brachial relapsing polychondritis) Bickerstaff’s encephalitis neuritis, brachial plexus neuropathy, Autoimmune angioedema Bladder pain syndrome (also known brachial plexitis, and Parsonage- Autoimmune aplastic anemia (also as interstitial cystitis) Turner syndrome) known as aplastic anemia) Brachial neuritis (also known as Acute disseminated Autoimmune cardiomyopathy brachial plexus neuropathy, brachial encephalomyelitis (ADEM) Autoimmune dysautonomia plexitis, Parsonage-Turner syndrome, Acute necrotizing hemorrhagic acute brachial neuropathy, acute Autoimmune hemolytic anemia leukoencephalitis brachial radiculitis, and neuralgic Acute parapsoriasis (also known as Autoimmune hepatitis amyotrophy) acute guttate parapsoriasis, acute Autoimmune hyperlipidemia Bullous pemphigoid pityriasis lichenoides, parapsoriasis Autoimmune immunodeficiency Castleman’s disease (also varioliformis, Mucha-Habermann C known as giant lymph node disease, and parapsoriasis or Autoimmune inner ear disease hyperplasia, lymphoid hamartoma, pityriasis lichenoides et varioliformis (AIED) and angiofollicular lymph node acuta) Autoimmune myocarditis
    [Show full text]